Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,563 | -8,517 | -5,236 | N/A | N/A |
| Depreciation Amortization | 90 | 12 | 11 | N/A | N/A |
| Accounts payable and accrued liabilities | -359 | 819 | 303 | N/A | N/A |
| Other Working Capital | -1,076 | 842 | 302 | N/A | N/A |
| Other Operating Activity | 1,539 | -792 | -300 | 0 | 0 |
| Operating Cash Flow | $-20,369 | $-7,636 | $-4,920 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -507 | -417 | N/A | N/A | N/A |
| Purchase Of Investment | -82,513 | -5,035 | -4,535 | N/A | N/A |
| Sale Of Investment | 6,069 | 3,673 | N/A | N/A | N/A |
| Investing Cash Flow | $-76,951 | $-1,779 | $-4,535 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 96,414 | 10,584 | 0 | 0 | 0 |
| Financing Cash Flow | $96,414 | $10,584 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 10,757 | 9,588 | 19,043 | N/A | N/A |
| End Cash Position | 9,851 | 10,757 | 9,588 | N/A | N/A |
| Net Cash Flow | $-906 | $1,169 | $-9,455 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,369 | -7,636 | -4,920 | N/A | N/A |
| Capital Expenditure | -507 | -417 | N/A | N/A | N/A |
| Free Cash Flow | -20,876 | -8,053 | -4,920 | 0 | 0 |